Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-24 6:55 pm Sale |
2025-03-21 | 13D | Haleon plc HLN |
PFIZER INC PFE |
0 0.000% |
-661,709,764 (Position Closed) |
Filing History |
| 2025-03-20 12:20 pm Unchanged |
2025-03-18 | 13D | Haleon plc HLN |
PFIZER INC PFE |
661,709,764 7.300% |
0 (Unchanged) |
Filing History |
| 2025-02-27 10:39 am Unchanged |
2025-02-25 | 13D | Haleon plc HLN |
PFIZER INC PFE |
661,709,764 7.300% |
0 (Unchanged) |
Filing History |
| 2025-02-12 2:51 pm Unchanged |
2024-12-31 | 13G | Zura Bio Limited ZURA |
PFIZER INC PFE |
2,970,022 4.600% |
0 (Unchanged) |
Filing History |
| 2025-02-12 2:48 pm Unchanged |
2024-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
PFIZER INC PFE |
2,411,575 3.600% |
0 (Unchanged) |
Filing History |
| 2025-01-21 6:26 pm Sale |
2025-01-17 | 13D | Haleon plc HLN |
PFIZER INC PFE |
661,709,764 7.300% |
-700,000,000 (-51.41%) |
Filing History |
| 2025-01-16 4:34 pm Unchanged |
2025-01-14 | 13D | Haleon plc HLN |
PFIZER INC PFE |
1,361,709,764 15.000% |
0 (Unchanged) |
Filing History |
| 2024-10-03 6:59 pm Sale |
2024-10-03 | 13D | Haleon plc HLN |
PFIZER INC PFE |
1,361,709,764 15.000% |
-700,526,315 (-33.97%) |
Filing History |
| 2024-10-01 7:38 pm Unchanged |
2024-09-30 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,062,236,079 22.600% |
0 (Unchanged) |
Filing History |
| 2024-08-05 6:12 pm Sale |
2024-08-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
0 0.000% |
-27,349,211 (Position Closed) |
Filing History |
| 2024-07-29 4:33 pm Unchanged |
2024-07-29 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,062,236,079 22.600% |
0 (Unchanged) |
Filing History |
| 2024-03-22 09:05 am Sale |
2024-03-21 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,062,236,079 22.600% |
-892,827,547 (-30.21%) |
Filing History |
| 2024-03-19 8:48 pm Unchanged |
2024-03-19 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,955,063,626 32.000% |
0 (Unchanged) |
Filing History |
| 2024-03-15 07:45 am Unchanged |
2024-01-29 | 13G | Tourmaline Bio, Inc. TRML |
PFIZER INC PFE |
1,272,214 4.960% |
0 (Unchanged) |
Filing History |
| 2024-02-14 3:48 pm Purchase |
2023-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR |
PFIZER INC PFE |
2,243,850 3.470% |
2,243,850 (New Position) |
Filing History |
| 2024-02-14 3:31 pm Purchase |
2023-12-31 | 13G | Enliven Therapeutics, Inc. ELVN |
PFIZER INC PFE |
389,429 0.950% |
389,429 (New Position) |
Filing History |
| 2024-02-14 2:29 pm Purchase |
2023-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
PFIZER INC PFE |
1,362,499 4.580% |
1,362,499 (New Position) |
Filing History |
| 2024-02-14 2:24 pm Purchase |
2023-12-31 | 13G | Cellectis S.A. CLLS |
PFIZER INC PFE |
2,786,924 3.890% |
2,786,924 (New Position) |
Filing History |
| 2024-02-14 2:19 pm Unchanged |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
PFIZER INC PFE |
2,525,252 4.530% |
0 (Unchanged) |
Filing History |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Pfizer Inc. PFE |
The Vanguard Group | 506,479,807 8.970% |
4,843,587 (+0.97%) |
Filing History |